(Q40455670)

20 September 2017

Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma. (English)

1 reference

20 September 2017

6

1 reference

20 September 2017

Elma Klein Kranenbarg

4

0 references

Michael W Kattan

2

object named as

Michael W Kattan

1 reference

20 September 2017

5

Martin S Karpeh

1 reference

20 September 2017

Koen C M J Peeters

1

1 reference

20 September 2017

Henk H Hartgrink

3

1 reference

20 September 2017

Cornelis J H van de Velde

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

20 September 2017

1 reference

20 September 2017

103

1 reference

20 September 2017

4

1 reference

20 September 2017

702-707

1 reference

Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma--a population-based study in Sweden

20 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Estimates of the worldwide incidence of 25 major cancers in 1990.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

The gastric cancer treatment controversy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Progress in gastric cancer surgery in Japan and its limits of radicality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Should systematic lymph node dissection be recommended for gastric cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

A competing-risks nomogram for sarcoma-specific death following local recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Extended lymph-node dissection for gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Evaluating the yield of medical tests

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Cancer of the stomach. A patient care study by the American College of Surgeons

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Gastric cancer: a curable disease in Britain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20783

7 January 2021

Identifiers

DOI

10.1002/CNCR.20783

1 reference

20 September 2017

1 reference